Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula
NCT05735964 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-03-04
Summary
This study aims to look at babies having a primary or delayed primary oesophageal repair for OA with dTOF to evaluate if using Indocyanine green (ICG) and near infrared fluorescence (NIRF) can decrease the rates of anastomotic leaks and/or predict which patients they will happen in. The latter evaluation would help counsel parents and mean that further research can evaluate if other tactics can prevent the leak being a moderate or severe problem. These may include, but not be limited to, extra anastomotic sutures, insertion of a chest drain at the time of surgery (if this had not previously been considered) delaying oral feeding or using medications to dry up the saliva prophylactically (these medications have been shown to reduce the length of time it takes leaks to seal). Any technique that can reduce leak rates in oesophageal atresia is to be welcomed.
Additionally ICG may artifactually affect both peripheral oxygen readings (cause a transient decrease) and cerebral near infrared spectroscopy (NIRS) values (cause a transient increase). This is due to the temporary, dose dependent, interference of the dye with the mechanism of action of the monitoring rather than a physiological effect on oxygen levels. To date there has been no study investigating the effects of ICG on oxygen saturation and cerebral NIRS in neonates undergoing OA and/or dTOF repair.
The theory is an extension from adult practice following oesophagectomy for cancer where there was a reduction in anastomotic leaks when using ICG/NIRF perfusion assessment. Another study in bariatric surgery using an enteral ICG/NIRF assessment was highly sensitive for anastomotic leaks allowing management of them intra-operatively.
Objectives are to
1. Identify if the appearances of ICG/NIRF can predict anastomotic leaks
2. Identify if the ICG/NIRF images would engender a change in operative management leading to a reduced leak rate
3. Give a detailed report on the effects of ICG on oxygen readings This would be a cohort pilot study of 20 patients with the aim of informing a subsequent multi-centre Randomised controlled trial
Conditions
- Tracheo-Esophageal Fistula with Atresia of Esophagus
Interventions
- DRUG
-
Indocyanine green
Intravenous and endoluminal dosing
Sponsors & Collaborators
-
Birmingham Women's and Children's NHS Foundation Trust
lead OTHER
Principal Investigators
-
Max Pachl · Birmingham Women's and Children's NHS Foundation Trust, UK
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
NCT02050971 ·Status: UNKNOWN ·Phase: PHASE1
-
Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO
NCT02851472 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Effects of Minimal Enteral Nutrition on Mesenteric Blood Flow and Oxygenation in Neonates With HIE
NCT06344286 ·Status: COMPLETED ·Phase: NA
-
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
NCT03919500 ·Status: COMPLETED ·Phase: PHASE2
-
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
NCT03835039 ·Status: TERMINATED
-
Measurement of Cerebral Oxygenation Using NIRS Method in the Preterm Infants With Intracranial Haemorrhagia
NCT01266889 ·Status: UNKNOWN
-
Tissue Oxygenation During Treatment of Infant Congenital Heart Defects
NCT03941015 ·Status: COMPLETED
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
NCT05853601 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Serum Erythropoietin Level in Perinatal Asphyxia
NCT05018364 ·Status: COMPLETED
-
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
NCT02793999 ·Status: RECRUITING
-
Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice
NCT03007563 ·Status: COMPLETED ·Phase: NA
-
Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
NCT00945789 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neonatal Erythropoietin in Asphyxiated Term Newborns
NCT00719407 ·Status: COMPLETED ·Phase: PHASE1
-
Healthy Little Eyes
NCT05971446 ·Status: RECRUITING
-
Neonates with Hypoxic Ischemic Encephalopathy (HIE)
NCT06694545 ·Status: NOT_YET_RECRUITING
-
MRI of Neonate With HIE Before and During the Moderate Hypothermia
NCT03079492 ·Status: UNKNOWN
-
Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy
NCT04021927 ·Status: WITHDRAWN ·Phase: NA
-
The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells
NCT03696745 ·Status: UNKNOWN ·Phase: PHASE1
-
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
NCT02564796 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Analyzing Retinal Microanatomy in ROP
NCT02887157 ·Status: COMPLETED
-
Reoxygenation for Cyanotic Pediatric CHD
NCT03568357 ·Status: UNKNOWN
-
Characterization of the Cord Blood Stem Cell in Situation of Neonatal Asphyxia
NCT01284673 ·Status: COMPLETED ·Phase: NA
-
umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)
NCT05100212 ·Status: COMPLETED ·Phase: PHASE2